Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024141 (
systemic lupus erythematosus
)
44,322
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
Budd-Chiari syndrome
(
BCS
) was diagnosed in a 30-year-old male hospitalized with hepatomegaly, abdominal collateral vessels and hepatic veins and inferior vena cava thrombosis (IVC) in 1988. The presence of circulating
lupus
anticoagulant (LAC) was suspected and demonstrated on this occasion in view of an earlier diagnosis of
systemic lupus erythematosus
(
SLE
) and recurrent vein thrombosis dating from 1981. There are sporadic reports of an association of
BCS
with
SLE
and other autoimmune diseases. The recent literature also describes associations with hypercoagulability due to LAC. These are reviewed together with the personal case to provide the rationale for correct diagnosis and therapy.
...
PMID:Association of the Budd-Chiari syndrome with lupus anticoagulant. Case report and critical review. 174 29
We describe a patient with the
lupus
anti-coagulant who had recurrent episodes, over a 2 year period, of a severe and disseminated intravascular coagulopathy. This patient also had positive serological assays for syphilis and anti-cardiolipin antibodies. Associated with the coagulopathy were co-expressed episodes of liver disease, ultimately terminating in fulminant liver failure. At autopsy the features were characteristic of the
Budd-Chiari syndrome
. This is the first report to document how consumptive coagulopathy may present as a dominant feature of the anti-phospholipid syndrome. It also clearly describes an immune mediated thrombotic mechanism as a cause of hepatic veno-occlusive disorders. Furthermore, this case highlights the varied clinical spectrum of the anti-phospholipid syndrome and suggests that a high index of suspicion is required to ensure its diagnosis.
...
PMID:Recurrent disseminated intravascular coagulation and fulminant intra hepatic thrombosis in a patient with the anti-phospholipid syndrome. 223 25
A 24-yr-old woman with hemolytic anemia developed multiple thrombosis of the hepatic vein and inferior vena cava. She was found to have circulating
lupus
anticoagulant that could have been causally related to the thrombosis and hence the
Budd-Chiari syndrome
. On her first admission to the hospital vena cava and hepatic vein catheterizations revealed partial thrombotic occlusion of the cava at the level of the diaphragm, which was subsequently transformed into complete membranous obstruction. The right hepatic vein, which was patent on the first admission, was also completely occluded. These observations support the theory that membranous obstruction of the inferior vena cava is a sequela to inferior vena caval thrombosis rather than a congenital anomaly.
...
PMID:Transformation of inferior vena caval thrombosis to membranous obstruction in a patient with the lupus anticoagulant. 308 75
A patient with
systemic lupus erythematosus
was first diagnosed after she had developed the
Budd-Chiari syndrome
. We believe that the
Budd-Chiari syndrome
was part of her tendency for thrombosis, induced by the presence of a
lupus
anticoagulant. The association between enhanced thrombosis and the
lupus
anticoagulant is discussed, and the need for prompt recognition and administration of anticoagulant therapy is emphasised.
...
PMID:Budd-Chiari syndrome as the major thrombotic complication of systemic lupus erythematosus with the lupus anticoagulant. 308
Three patients with
Budd-Chiari syndrome
in association with the '
lupus
' anticoagulant are described. This anticoagulant was looked for in our patients with an otherwise idiopathic hepatic venous thrombosis because of the presence of a pronounced thrombocytopenia, a prolonged activated partial thromboplastin time or a history of repeated abortions and deep leg vein thrombosis, respectively. An active search for the '
lupus
' anticoagulant should be performed to lower the percentage of apparently idiopathic cases of
Budd-Chiari syndrome
.
...
PMID:'Lupus' anticoagulant and thrombosis of the hepatic veins (Budd-Chiari syndrome). Report of three patients and review of the literature. 309 80
Lupus
anticoagulant, an immunoglobulin that prolongs the partial thromboplastin time, has been associated with thrombotic events, including deep venous thrombosis, pulmonary emboli, and
Budd-Chiari syndrome
. In this report, primary sclerosing cholangitis was diagnosed in a man with a 10-year history of multiple thrombotic events related to a circulating
lupus
anticoagulant. Progressive jaundice and pruritus developed, and sclerosing cholangitis was confirmed by direct cholangiography. Sclerosing cholangitis is the second hepatobiliary disease reported in association with a
lupus
anticoagulant.
...
PMID:Primary sclerosing cholangitis in the presence of a lupus anticoagulant. 309 67
Chronic constrictive pericarditis may complicate both rheumatoid arthritis and
systemic lupus erythematosus
. To our knowledge, however, this is the first time it has been described in a patient with dermatomyositis. This association should be kept in mind as constrictive pericarditis should be considered in the differential diagnosis of liver cirrhosis and
Budd-Chiari syndrome
in rheumatic diseases.
...
PMID:Constrictive pericarditis complicating dermatomyositis. 320 78
Lupus
anticoagulant is an immunoglobulin that interferes with prothrombin conversion to thrombin and is manifested biochemically by prolongation of the partial thromboplastin time. Paradoxically, bleeding is rare in association with this anticoagulant, and deep leg vein thromboses, pulmonary emboli, and cerebrovascular accidents have been described in patients with this clotting inhibitor. This report describes the first case of
Budd-Chiari syndrome
associated with the
lupus
anticoagulant. The patient presented with abdominal pain and massive ascites. The
Budd-Chiari syndrome
was confirmed by liver biopsy and venography. No medical condition known to predispose to an increased thrombotic tendency could be identified, and the presence of the
lupus
anticoagulant in the patient's plasma may provide an explanation for his hypercoagulability and development of the
Budd-Chiari syndrome
.
...
PMID:Budd-Chiari syndrome in a patient with the lupus anticoagulant. 641 18
Endogenous circulating anticoagulants are unusual in children without a congenital factor deficiency. In particular, the
lupus
anticoagulant has only rarely been reported in children. Despite its functioning in vitro to prolong the partial thromboplastin time, patients more frequently have problems with thrombosis than bleeding, unless there is a coexistent prothrombin deficiency or thrombocytopenia. We report the cases of three children with the
lupus
anticoagulant. Two children had associated thromboses. One had a thrombosis of the iliofemoral system and the other had a partial
Budd-Chiari syndrome
, a thrombosis of the deep calf veins and ureteric obstruction. The third child had a concomitant prothrombin deficiency and bleeding after tooth extraction. Associated findings in these patients included a positive antinuclear antibody test in two, a positive anti-DNA antibody test in two, a false-positive VDRL test in two, and an antiphospholipid antibody test in two.
...
PMID:Thrombotic and hemorrhagic complications in children with the lupus anticoagulant. 643 32
The
Budd-Chiari syndrome
is an uncommon condition in which hepatic venous outflow is obstructed by thrombosis of the major hepatic veins. Many of the cases are idiopathic, but it has been described in association with vena caval webs, abdominal trauma, retroperitoneal neoplasms, and hypercoagulable states. A patient with
systemic lupus erythematosus
(
SLE
) who developed the
Budd-Chiari syndrome
with inferior vena cava thrombosis led to a review of the possible association between
SLE
and the
Budd-Chiari syndrome
. The therapy of the
Budd-Chiari syndrome
with associated vena cava thrombosis is also discussed.
...
PMID:Budd-Chiari syndrome with inferior vena cava obstruction associated with systemic lupus erythematosus. 672 16
1
2
3
4
Next >>